共 50 条
- [1] Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO studyLEUKEMIA & LYMPHOMA, 2023, 64 (02) : 468 - 472Nahi, Hareth论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, Sweden Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenUsmani, Saad Z.论文数: 0 引用数: 0 h-index: 0机构: Memorial Sloan Kettering Canc Ctr, New York, NY USA Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenMateos, Maria-Victoria论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Salamanca, IBSAL, Canc Res Ctr, IBMCC USAL CSIC, Salamanca, Spain Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, Swedenvan de Donk, Niels W. C. J.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Hematol, Amsterdam, Netherlands Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenOriol, Albert论文数: 0 引用数: 0 h-index: 0机构: Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Barcelona, Spain Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenPlesner, Torben论文数: 0 引用数: 0 h-index: 0机构: Vejle Hosp, Vejle, Denmark Univ Southern Denmark, Vejle, Denmark Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenBandyopadhyay, Nibedita论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenHellemans, Peter论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Beerse, Belgium Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenTromp, Brenda论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Leiden, Netherlands Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenNnane, Ivo论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenZemlickis, Donna论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Toronto, ON, Canada Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenChari, Ajai论文数: 0 引用数: 0 h-index: 0机构: Icahn Sch Med Mt Sinai, New York, NY USA Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, SwedenMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Hotel Dieu, Hematol Dept, Nantes, France Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Hematol, Dept Med, Huddinge, Sweden
- [2] Subcutaneous Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma: Part 2 Safety and Efficacy Update of the Open-Label, Multicenter, Phase 1b Study (PAVO)BLOOD, 2018, 132Chari, Ajai论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAMateos, Maria-Victoria论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Salamanca, IBSAL, Salamanca, Spain Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAvan de Donk, Niels W. C. J.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAKaufman, Jonathan L.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Nantes, Nantes, France Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAOriol, Albert论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol, HGTiP, Barcelona, Spain Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAPlesner, Torben论文数: 0 引用数: 0 h-index: 0机构: Vejle Hosp, Vejle, Denmark Univ Southern Denmark, Vejle, Denmark Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USABenboubker, Lotfi论文数: 0 引用数: 0 h-index: 0机构: CHRU, Hop Bretonneau, Serv Hematol & Therapie Cellulaire, Tours, France Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USANahi, Hareth论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, Sweden Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USATang, Jie论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAHellemans, Peter论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Beerse, Belgium Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USATromp, Brenda论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Beerse, Belgium Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAClemens, Pamela L.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAFarnsworth, Andrew论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, High Wycombe, Bucks, England Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USASan-Miguel, Jesus F.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, Spain Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAUsmani, Saad Z.论文数: 0 引用数: 0 h-index: 0机构: Atrium Hlth, Levine Canc Inst, Charlotte, NC USA Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA
- [3] Subcutaneous daratumumab (DARA) in patients (Pts) with relapsed or refractory multiple myeloma (RRMM): Part 2 update of the open-label, multicenter, dose escalation phase 1b study (PAVO).JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Chari, Ajai论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAUsmani, Saad Zafar论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAMateos, Maria-Victoria论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAVan De Donk, Niels论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAKaufman, Jonathan L.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USARocafiguera, Albert Oriol论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAPlesner, Torben论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USABenboubker, Lotfi论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USALiu, Kevin论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAHellemans, Peter论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAMasterson, Tara J.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAClemens, Pamela L.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USAFarnsworth, Andrew论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USANahi, Hareth论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USASan-Miguel, Jesus论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA
- [4] SUBCUTANEOUS DARATUMUMAB IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): AN OPEN-LABEL, MULTICENTER, DOSE ESCALATION PHASE 1B STUDY (PAVO)HAEMATOLOGICA, 2018, 103 : 32 - 33Mateos, M., V论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Salamanca, IBSAL, Salamanca, Spain Univ Hosp Salamanca, IBSAL, Salamanca, SpainChari, A.论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA Univ Hosp Salamanca, IBSAL, Salamanca, SpainNah, H.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Dept Med, Div Hematol, Karolinska Univ Hosp Huddinge, Stockholm, Sweden Univ Hosp Salamanca, IBSAL, Salamanca, SpainLokhorst, H.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands Univ Hosp Salamanca, IBSAL, Salamanca, SpainKaufman, J. L.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA Univ Hosp Salamanca, IBSAL, Salamanca, SpainMoreau, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Nantes, Nantes, France Univ Hosp Salamanca, IBSAL, Salamanca, SpainOriol, A.论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol, HGTiP, Girona, Spain Univ Hosp Salamanca, IBSAL, Salamanca, SpainPlesner, T.论文数: 0 引用数: 0 h-index: 0机构: Vejle Hosp, Vjele, Denmark Univ Southern Denmark, Odense, Denmark Univ Hosp Salamanca, IBSAL, Salamanca, SpainBenboubker, L.论文数: 0 引用数: 0 h-index: 0机构: CHRU, Hop Bretonneau, Serv Hematol & Therapie Cellulaire, Paris, France Univ Hosp Salamanca, IBSAL, Salamanca, SpainHellemans, P.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Univ Hosp Salamanca, IBSAL, Salamanca, SpainMasterson, T.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Univ Hosp Salamanca, IBSAL, Salamanca, SpainClemens, P. L.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Univ Hosp Salamanca, IBSAL, Salamanca, SpainLiu, K.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Univ Hosp Salamanca, IBSAL, Salamanca, SpainSan-Miguel, J.论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra, IDISNA, CIMA, CIBERONC, Navarra, Spain Univ Hosp Salamanca, IBSAL, Salamanca, SpainUsmani, S. Z.论文数: 0 引用数: 0 h-index: 0机构: Carolinas HealthCare Syst, Levine Canc Inst, Charlotte, NC USA Univ Hosp Salamanca, IBSAL, Salamanca, Spain
- [5] Open-Label, Multicenter, Dose Escalation Phase 1b Study to Assess the Subcutaneous Delivery of Daratumumab in Patients (pts) with Relapsed or Refractory Multiple Myeloma (PAVO)BLOOD, 2016, 128 (22)Usmani, Saad Z.论文数: 0 引用数: 0 h-index: 0机构: Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USANahi, Hareth论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp, Karolinska Inst, Div Hematol, Huddinge, Sweden Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAMateos, Maria-Victoria论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Salamanca IBSAL, Salamanca, Spain Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USALokhorst, Henk M.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAChari, Ajai论文数: 0 引用数: 0 h-index: 0机构: Tisch Canc Inst, Mt Sinai Sch Med, New York, NY USA Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAKaufman, Jonathan L.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Atlanta, GA USA Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Nantes Univ Hosp, Dept Hematol, Nantes, France Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAOriol, Albert论文数: 0 引用数: 0 h-index: 0机构: HGTiP, Inst Catala Oncol, Barcelona, Spain Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAPlesner, Torben论文数: 0 引用数: 0 h-index: 0机构: Univ So Denmark, Vejle Hosp, Ctr Little Belt, Dept Hematol, Vejle, Denmark Vejle Hosp, Dept Hematol, Vejle, Denmark Univ So Denmark, Vejle, Denmark Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USABenboubker, Lotfi论文数: 0 引用数: 0 h-index: 0机构: CHU Tours Hop Bretonneau, Tours, France Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAHellemans, Peter论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Beerse, Belgium Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAMasterson, Tara论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAClemens, Pamela L.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, LLC, Spring House, PA USA Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USAAhmadi, Tahamtan论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, LLC, Spring House, PA USA Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USALiu, Kevin论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, LLC, Raritan, NJ USA Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USASan-Miguel, Jesus论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra CIMA, IDISNA, Pamplona, Spain Levine Canc Inst Carolinas HealthCare Syst, Dept Hematol Oncol & Blood Disorders, Charlotte, NC USA
- [6] Subcutaneous Delivery of Daratumumab in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM): Pavo, an Open-Label, Multicenter, Dose Escalation Phase 1b StudyBLOOD, 2017, 130Chari, Ajai论文数: 0 引用数: 0 h-index: 0Nahi, Hareth论文数: 0 引用数: 0 h-index: 0Mateos, Maria-Victoria论文数: 0 引用数: 0 h-index: 0Lokhorst, Henk M.论文数: 0 引用数: 0 h-index: 0Kaufman, Jonathan L.论文数: 0 引用数: 0 h-index: 0Moreau, Philippe论文数: 0 引用数: 0 h-index: 0Oriol, Albert论文数: 0 引用数: 0 h-index: 0Plesner, Torben论文数: 0 引用数: 0 h-index: 0Benboubker, Lotfi论文数: 0 引用数: 0 h-index: 0Hellemans, Peter论文数: 0 引用数: 0 h-index: 0Masterson, Tara论文数: 0 引用数: 0 h-index: 0Clemens, Pamela L.论文数: 0 引用数: 0 h-index: 0Liu, Kevin论文数: 0 引用数: 0 h-index: 0San-Miguel, Jesus F.论文数: 0 引用数: 0 h-index: 0Usmani, Saad Z.论文数: 0 引用数: 0 h-index: 0
- [7] Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma part 2 of the open-label, multicenter, dose-escalation phase Ib study (PAVO)HAEMATOLOGICA, 2021, 106 (06) : 1725 - 1732San-Miguel, Jesus论文数: 0 引用数: 0 h-index: 0机构: Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, Spain Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainUsmani, Saad Z.论文数: 0 引用数: 0 h-index: 0机构: Atrium Hlth, Levine Canc Inst, Charlotte, NC USA Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainMateos, Maria-Victoria论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Salamanca IBSAL, Salamanca, Spain Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, Spainvan de Donk, Niels W. C. J.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam, Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainKaufman, Jonathan L.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Nantes, Nantes, France Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainOriol, Albert论文数: 0 引用数: 0 h-index: 0机构: Inst Catala Oncol, HGTiP, Barcelona, Spain Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainPlesner, Torben论文数: 0 引用数: 0 h-index: 0机构: Vejle Hosp, Vejle, Denmark Univ Southern Denmark, Vejle, Denmark Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainBenboubker, Lotfi论文数: 0 引用数: 0 h-index: 0机构: Hop Bretonneau, Ctr Hosp Reg Univ CHRU, Serv Hematol & Therapie Cellulaire, Tours, France Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainLiu, Kevin论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainHellemans, Peter论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Beerse, Belgium Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainMasterson, Tara论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainClemens, Pamela L.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainLuo, Man论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainFarnsworth, Andrew论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, High Wycombe, Bucks, England Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainNahi, Hareth论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Div Hematol, Stockholm, Sweden Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, SpainChari, Ajai论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA Clin Univ Navarra CIMA, IDISNA, CIBERONC, Pamplona, Spain
- [8] Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving subcutaneous daratumumab (DARA SC): Part 3 of the open-label, multicenter, phase Ib PAVO Study.JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)Nahi, Hareth论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenUsmani, Saad Zafar论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenMateos, Maria-Victoria论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, Swedenvan de Donk, Niels W. C. J.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenOriol, Albert论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenPlesner, Torben论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenYang, Shiyi论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenHellemans, Peter论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenTromp, Brenda J.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenLuo, Man论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenZemlickis, Donna论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenFarnsworth, Andrew论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, SwedenChari, Ajai论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, Sweden
- [9] Pharmacokinetics (PK) of Subcutaneous Daratumumab in Patients with Relapsed or Refractory (RR) Multiple Myeloma (MM): Primary Clinical Pharmacology Analysis of the Open-Label, Multicenter, Phase 1b Study (PAVO)BLOOD, 2018, 132Clemens, Pamela L.论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Janssen Res & Dev LLC, Spring House, PA USAXu, Steven论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Janssen Res & Dev LLC, Spring House, PA USALuo, Melody论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Janssen Res & Dev LLC, Spring House, PA USAChari, Ajai论文数: 0 引用数: 0 h-index: 0机构: Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA Janssen Res & Dev LLC, Spring House, PA USAUsmani, Saad Z.论文数: 0 引用数: 0 h-index: 0机构: Atrium Hlth, Levine Canc Inst, Charlotte, NC USA Janssen Res & Dev LLC, Spring House, PA USAMateos, Maria-Victoria论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Salamanca, IBSAL, Salamanca, Spain Janssen Res & Dev LLC, Spring House, PA USAvan de Donk, Niels W. C. J.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam, Med Ctr, Dept Hematol, Amsterdam, Netherlands Janssen Res & Dev LLC, Spring House, PA USAKaufman, Jonathan L.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA Janssen Res & Dev LLC, Spring House, PA USAMoreau, Philippe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Nantes, Nantes, France Janssen Res & Dev LLC, Spring House, PA USAOriol, Albert论文数: 0 引用数: 0 h-index: 0机构: HGTiP, Inst Catala Oncol, Barcelona, Spain Janssen Res & Dev LLC, Spring House, PA USAPlesner, Torben论文数: 0 引用数: 0 h-index: 0机构: Vejle Hosp, Vejle, Denmark Univ Southern Denmark, Vejle, Denmark Janssen Res & Dev LLC, Spring House, PA USABenboubker, Lotfi论文数: 0 引用数: 0 h-index: 0机构: CHRU, Hop Bretonneau, Serv Hematol & Therapie Cellulaire, Tours, France Janssen Res & Dev LLC, Spring House, PA USASan-Miguel, Jesus F.论文数: 0 引用数: 0 h-index: 0机构: CIBERONC, IDISNA, Clin Univ Navarra CIMA, Pamplona, Spain Janssen Res & Dev LLC, Spring House, PA USASun, X. Yu-Nien论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Janssen Res & Dev LLC, Spring House, PA USAFarnsworth, Andrew论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, High Wycombe, Bucks, England Janssen Res & Dev LLC, Spring House, PA USAMasterson, Tara论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Janssen Res & Dev LLC, Spring House, PA USAHellemans, Peter论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Beerse, Belgium Janssen Res & Dev LLC, Spring House, PA USAQi, Ming论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Janssen Res & Dev LLC, Spring House, PA USANahi, Hareth论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Karolinska Inst, Stockholm, Sweden Janssen Res & Dev LLC, Spring House, PA USA
- [10] Subcutaneous daratumumab in Chinese patients with relapsed or refractory multiple myeloma: an open-label, multicenter, phase 1 study (MMY1010)BLOOD SCIENCE, 2024, 6 (03): : e00193An, Gang论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaGe, Zheng论文数: 0 引用数: 0 h-index: 0机构: Southeast Univ, Zhongda Hosp, Dept Hematol, Nanjing 210009, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaJing, Hongmei论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Third Hosp, Beijing 100191, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaLiu, Jing论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp 3, Dept Hematol, Changsha 410013, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaYang, Guoping论文数: 0 引用数: 0 h-index: 0机构: Cent South Univ, Xiangya Hosp 3, Dept Hematol, Changsha 410013, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaFeng, Ru论文数: 0 引用数: 0 h-index: 0机构: Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou 510515, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaXu, Zhongyuan论文数: 0 引用数: 0 h-index: 0机构: Southern Med Univ, Nanfang Hosp, Phase Clin Trial Dept 1, Guangzhou 510515, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaQi, Ming论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA 19477 USA Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaWang, Jianping论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA 19477 USA Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaSong, Juanjuan论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Shanghai, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaZhou, Wei论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Shanghai, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaSun, Binbin论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Shanghai 200231, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaZhu, Dian论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Shanghai 200231, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaChen, Xi论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Shanghai 200231, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaCui, Canchan论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Shanghai, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R ChinaQiu, Lugui论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Hematol Disorders, 288 Nanjing Rd, Tianjin 300020, Peoples R China